You are viewing the site in preview mode

Skip to main content

Table 2 Clinical characteristics of PD patients

From: Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder

  pRBD+ pRBD- p
Hoehn & Yahr stage 2.40 ± 0.90 2.26 ± 0.90 0.299
UPDRS III(total) 26.93 ± 14.62 23.68 ± 15.93 0.174
Bradykinesia (23–26) 8.87 ± 7.05 7.40 ± 6.11 0.292
Freezing, n (%) 8 (26.7) 25 (22.52) 0.750
LcompareA 5.67 ± 4.22 6.17 ± 4.61 0.734
RcompareT 3.01 ± 4.06 1.79 ± 2.08 0.320
PDSS 17.50 ± 9.60 11.70 ± 8.55 <0.001
MMSE 25.30 ± 3.91 26.75 ± 3.97 0.017
HAMA 7.53 ± 5.51 4.53 ± 6.38 0.002
HAMD 10.83 ± 8.60 5.39 ± 7.12 <0.001
Hallucination, n (%) 6 (20.00) 7 (6.30) 0.032
Dementia, n (%) 5(16.67) 13(11.71) 0.538
Anxiety, n (%) 18 (60.00) 25 (22.52) <0.001
Depression, n (%) 19 (63.33) 27 (24.32) <0.001
Hyposmia, % 46.67 35.16 0.247
Constipation, % 80.00 57.66 0.033
Orthostatic hypotension, n (%) 7 (23.33) 7 (6.30) 0.012
  1. LcompareA (UPDRS III): UPDRS score in limb compare with axial; RcompareT (UPDRS III): UPDRS score in rigidity compare with tremor; n Number
  2. The pRBD+ PD patients had significantly higher rates of anxiety, depression and visual hallucinations rates. And they had a higher mean PDSS score. Dementia was not significantly difference between two groups. Constipation and OH were more prominent in the pRBD+ group